Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : UCB Pharma S.A
Deal Size : Undisclosed
Deal Type : Acquisition
UCB Acquires Handl Therapeutics BV
Details : Acquisition of Handl Therapeutics BV augments UCB’s existing early gene therapy pipeline with two research programs, a proprietary adeno-associated virus (AAV) capsid technology platform and capabilities.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 11, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : UCB Pharma S.A
Deal Size : Undisclosed
Deal Type : Acquisition